Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT06673433
Active, not recruiting Observational

The Effects of Environmental Factors on the Macro-genome and Metabolism of Obese Patients.

NCT06673433 · tracked via the Priya Life Science China tracker
Sponsor
Dong Peng
Phase
Observational
Started
2022-10-01
Last updated
2025-06-02

Condition(s) studied

Obesity and Overweight

Investigational drug(s) / intervention(s)

obesityhealth

obesity: Patients diagnosed with obesity (BMI ≥ 28kg/m2)

health: the health control group include paticipants with nomal BMI

Study summary

The present study was designed to include obese patients diagnosed with obesity in the First Affiliated Hospital of Chongqing Medical University and a healthy control population. By analysing the relationship between metabolic parameters and macrogenomes in obesity, identifying key metabolic and macrogenomic differences between obese patients and healthy populations, and establishing the association between environmental factors and obesity-related metabolic disorders, the investigators will be able to provide new biomarkers and intervention targets for obesity prevention and treatment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Age ≥18 years; * Obese patients with BMI ≥30kg/m2; * Patients did not undergo surgical treatment before enrolment; * Willing to participate in this study and sign the informed consent form; * Complete clinical data. Exclusion Criteria: * Patients with systemic diseases such as severe cardiorespiratory insufficiency that affect the choice of treatment regimen; * Pregnant or lactating women; * Patients who are not suitable for enrolment as assessed by the investigator; * Patients with incomplete clinical data.

Primary outcome measure(s)

  • BMI — BMI was examed when first join the study, whith through the whole study period, an average of 1 month.
    BMI = weight / height squared (kg/m2)

Trial sites (1)

FacilityCityRegionStatus
The First Affiliated Hospital of Chongqing Medical University Chongqing Chongqing Municipality

More Dong Peng trials in China

Impact of Environmental Factors and Metabolomics on Colorectal Cancer. Active, not recruiting
Microplastics in Paraneoplastic and Intratumoral for Colorectal Cancer Active, not recruiting
The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome Active, not recruiting
Impact of Pre- and Post-operative Serum Metabolome Dynamics in Colorectal Resection Outcomes Active, not recruiting
Predictive Value of Air Pollution and Metabolomics for Gastric Cancer. Active, not recruiting

Other trials for the same condition

A Study of IBI3046 in Participants With Overweight or Obesity Recruiting
Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens Recruiting
Identification of Microplastics in Liver, Stomach, Blood, and Feces of Obese Patients and Their Association Analysis with Macrogenomics and Metabolomics. Active, not recruiting
Efficacy of Different Dietary Pattern in Long-term Weight Management Starting soon
The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT) Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06673433 on ClinicalTrials.gov ↗ ← All trials in China